Open Access

Optimal test design for binary response data: the example of the fish embryo toxicity test

Environmental Sciences EuropeBridging Science and Regulation at the Regional and European Level201527:15

https://doi.org/10.1186/s12302-015-0046-5

Received: 8 October 2014

Accepted: 5 June 2015

Published: 7 July 2015

Abstract

Background

The fish embryo toxicity test (FET) is an established method in toxicology research for quantifying the risk potential of environmental contaminations and other substances. The typical results of the method are the half maximal effective concentration (EC50) or the no observed effect concentration (NOEC). However, from an environmental perspective, it is most important to safely identify the concentration of the substance effect which lies above the effect under control condition (spontaneous effect). The common FET is not optimal to detect ECs for small target effects. This paper shows how to optimize the efficiency and consequently the benefit of the FET for small effects using an adequate experimental design. The approach presented here can be carried over to all test systems generating binary (yes/no) outcomes.

Results

The experimental design has three components in this context: determination of spontaneous response, sample size calculation, and dose allocation. A strategy for all three components is proposed from which a design is given including precision requirements and makes the most effective use of the experimental effort. This strategy amounts to expanding the usual FET guidelines of Organisation for Economic Co-operation and Development, German Institute for Standardization, or American Society for Testing and Materials by adding a planning step that adapts the test to the specific user’s need.

Conclusions

For the practical calculation of an adapted design, a newly developed software is presented as R package toxtestD. It provides a user-friendly way of developing an optimal experimental design for the FET without in-depth statistical knowledge. The programme is suited for all experimental problems involving a binary outcome and a continuous concentration.

Keywords

Toxicity test planning R statistic package Zebrafish embryo Spontaneous lethality Sample size Dose design

Background

Toxicity tests in ecotoxicology serve to detect and quantify toxic properties of chemical substances. Typically, a toxicity test is a laboratory test, which means that the experimenter chooses the test procedure, the number of subjects to test, the doses or concentrations to apply, as well as the appropriate way to quantify toxicity. Such quantifications are used to set thresholds for allowable concentrations in the environment. Choices in experimental design should ensure high quality of the results in terms of precise and unbiased toxicity quantification and of statistical decisions with controlled error rates. The design should also make optimal use of the experimental effort. A proper experimental design is frequently demanded, but only a few publications on risk assessment deal with this aspect in detail. In this paper we use the fish embryo toxicity test (FET) as an example to demonstrate how to design a toxicity experiment attaining the required precision of results. We also include considerations on how to quantify toxicity using the FET results. The procedure proposed involves a four-parameter logistic dose-response model, which allows incorporating spontaneous effects as well as non-effects due to an insusceptible subpopulation. For the numerical operations of planning and analysis, we provide the R package toxtestD, whose reference manual can be downloaded from the CRAN homepage [1, 2].

In recent years, FET has predominantly replaced the fish acute toxicity test [3, 4]. Research projects like DanTox favour the embryos of the model organism Danio rerio to identify toxicity processes [5]. The classical version of the FET is established in research laboratories as well as in service laboratories [68].

A core component of the FET is exposing fertilized eggs, preferentially from zebrafish (D. rerio), in an early stage of cell division to an aquatic compound, which is charged with harmful substances. Responses to the tested substance can be death, coagulation, lethal or sublethal malformations, or teratogenic effects. The presence of effects is examined after 48 or 96 h post fertilization (hpf) [9, 4]. This test setup is used because early life stages are more sensitive than the adult life stage. In addition, early life stage tests operate faster than tests on full-grown parental fishes [10]. Following the norm of the German Institute of Standardization (DIN), ten fertilized, normally developed eggs per concentration and a negative control should be tested [4]. The Organisation for Economic Co-operation and Development (OECD) guideline recommends 20 eggs per test concentration and positive control, respectively, and 24 eggs per negative control [9]. Both guidelines accept up to 10 % spontaneous deaths among negative controls [4, 9].

Effect quantification

Effect quantification means expressing the toxicity of a substance by a single number. The full information about the relation between concentration and toxicity (effect) is described by the concentration-response relation (see example in Fig. 1a). A major concept of effect quantification is the no observed effect concentration (NOEC). It is the result of comparing observed effects in treated groups to the effects observed in the control group. The other major effect quantification is the effective concentration value (ECxx). It denotes the concentration which causes an effect of xx %. Depending on its application, ECxx has been varyingly labelled as effective dose (EDxx), lethal concentration/dose (LCxx/LDxx), benchmark dose (BMD), or virtual safe dose (VSD, for very small xx) (OECD 2013 [11]). Both concepts differ clearly with regard to their properties and interpretation.
Fig. 1

Sample size calculation. Logistic distribution of a concentration-response relationship (line) with a confidence interval (dotted lines around). a Difference between SL and TR xx at the dose-response curve (green arrow) marks the basic distance for calculation of the sample size. The confidence interval of SL is not shown. b Calculation of the sample size with the two different distributions of SL (light grey line) and a treated group (dark grey line). Under the restrictions of alpha and beta (red marked areas) will the optimal number of individuals be estimated (green line). IY immunity, SL spontaneous lethality, TR total risk, xx target value

NOEC, the controversial legacy

As stated by the guidance for the implementation of REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals), the NOEC is ‘the highest tested concentration for which there is no statistical significant difference of effect when compared to the control group’ [12]. Similar to other statistical tests, the test sequence leading to the NOEC will detect a substance-related effect with a given safety only if it has a certain size. The detectable size and the probability of detection depend on sample size, the number of concentration points, and their allocation. Changing the sample size may shift the NOEC value over the whole range of tested concentrations, e.g. if a test sequence is repeated with the identical set of concentrations, but with a different number of replicates per concentration, the highest concentration tested (for few replicates) or the smallest concentration (for many replicates) or a concentration somewhere in between may result as NOEC [13]. The high importance of sample size becomes evident when looking at a simple example: if a concentration causes one of 20 organisms to show an effect, but only 10 organisms are tested, it is not very likely that the experimenter will see an effect at all. Generally, an existing effect may be accidentally missed due to a too small sample size, an unfortunate choice of concentrations or just by chance [14].

The abbreviation NOEC contains the wording of a ‘no observed effect’ [15], and the NOEC only indicates a concentration which could not be shown to cause a response. However, in some cases, NOEC seems to be misunderstood as indicating a concentration that produces generally ‘no effect’, particularly when no effect was observed in the actual experiment. But a true effect greater than zero may be undetected in an experiment simply because of a small sample size. It would be seen in an experiment with larger sample size. A power calculation would unveil this situation. In a NOEC analysis involving only few replicates, the detection of a small effect cannot be expected due to the small statistical power of a statistical test on binary effects with few replicates [14]. As a NOEC is typically reported without the circumstances of its genesis, a user cannot comprehend whether a high NOEC is either due to weak toxicity or to an experiment with few replicates [15]. Moreover, NOECs from two experiments with different concentration patterns and varying replicate numbers can hardly be compared. Guidelines try to establish a minimum of experimental standards; nevertheless, resulting NOECs fluctuate still between concentrations generating 10 and 30 % effect [16]. NOECs are therefore considered as highly problematic in the scientific discussion [17, 15, 18].

Parametric modelling

The ECxx calculation relies on a parametric assumption about the concentration-response relation (concentration-response curve) underlying the data. ECxx links the pre-specified effect level to the effective concentration [19]. Presumably, the most frequently used target effect value is the mean effective concentration (EC50), which relates to a mean response of 50 % [20]. Different from NOEC, a confidence interval (CI) can be calculated for both the whole curve and for every ECxx value. The width of the CI for ECxx is affected by the number of replications and the concentration allocation pattern. This can be exploited to set up an optimal experimental design that makes best use of the experimental effort. The ECxx concept is commonly preferred over NOEC because of its fewer problematic attributes [12], in particular, for the fact that the expected value of ECxx does not depend on sample size and that a confidence interval can be given.

Target shift to small effect sizes for threshold calculations

The effects of much smaller sizes than 50 % need to be detected to determine concentrations acceptable for health level and environmental conservation. Therefore, the target of the experiment is shifted towards smaller effects. The detection of small effects is necessary for employment and environmental protection to define concentration thresholds that should not be exceeded in order to keep the amount of adverse effects (response) due to exposure below the tolerable level [21, 22]. All ECs should be calculated from a concentration-response curve fitted to observed response data. Approximate calculations of ECxx for small xx lead to diverging results as a consequence if controversial safety or assessment factors become necessary to apply [23]. Concluding the ECxx from EC50 is an unsafe operation, as the difference between ECxx and EC50 depends on the slope of the concentration-response curve, which is unknown and cannot be concluded from EC50. The NOEC is by definition neither related to the size of an effect nor to a concentration-response curve; therefore, no ECxx can reasonably be concluded from the NOEC. Small responses just above zero are generally hard to detect by a statistical test and proving the probability of a detectable response at zero requires an infinitely large number of biological objects in the test. As an example, if the substance effect increases and consequently the effect rate rises by 0.000001 (= 0.0001 %), the experimental group must contain at least 1/0.000001 = 1,000,000 objects to make the expected increase in response (by only one object) visible. In reality, experiments are designed with much smaller sample sizes simply for logistic reasons. This means that only concentrations with an effect clearly above zero can be detected, whereas the exact meaning of ‘clearly above zero’ needs to be calculated during planning and design of the experiment. It depends on sample size as well as on concentration-response relation. The required effect size, in order to fulfill the aim of the experiment, needs to be assessed for each particular problem. It defines the tolerable level mentioned above. Typically, a substance effect in the range of 1 to 10 % is set as tolerable level. This directs the focus on effect concentrations like EC01, EC05, and EC10.

Changes in experimental design as a first step

In the discussion about how thresholds should be derived, the danger of using an insufficient data set has been identified as a basic point [17]. Actual norms and guidelines are optimized in regard to economic advisements [24]. Reducing time and equipment-dependent costs (including the number of organisms) when estimating a concentration-effect relationship seems to be more honoured than safely protecting the environment [25]. An example for a questionable proceeding is designing an experiment with high concentrations causing high effects and extrapolating the obtained data to the low effect situation. As fewer biological objects are needed, this approach has the advantage of being easier and more cost-efficient than an experiment with low doses, in which a higher number of objects is needed to generate effects [26]. The extrapolation strategy increases the random error of the estimated EC [17]. An adjustment for low risk effects is not considered in the procedure of OECD guidelines, which is typically proposed only for the optimal determination of EC50.

We recommend determining ECxx for small xx by organizing the FET according to the purpose of detecting small effects and then to estimate ECxx from a fitted concentration-response curve. When developing an optimal design for small effect detection, it should be recalled that the FET is used in laboratory experiments, which gives full control over the experimental conditions, i.e. the number of different concentrations, the concentrations themselves, and the number of biological objects per concentration. This freedom will be exploited when developing an optimal design. Only small modifications of the standard FET are necessary to adjust to the shifted target question. The main steps in designing a FET experiment are choosing appropriate effect quantification, followed by setting up an optimal plan for the sample size, the number of concentrations, and the concentration allocations. In this context, optimal means determining the concentration of interest with a given precision while using as few organisms as possible.

Results and discussion

Before developing an experimental design for a toxicity test, a decision must be made on how to quantify the toxic effect. Both concepts presented, the NOEC and the ECxx, have their merits and disadvantages.

The interpretation of a NOEC without additional information is not statistically sound. The NOECs state that when comparing the response of a control group to that of a group exposed to the NOEC concentration, no significant difference in response could be found. This may have two reasons: either there was really no difference in responses, or there was a difference in responses that could not be detected by the test due to the (too small) group size. As the number of cases per group is typically neither reported nor generally standardized, the effect size that may have been undetected is unknown and cannot be calculated. Therefore, there is a danger of underestimating the effect potential when using the NOEC compared to an effect-based analysis [17]. ECxx has a clear interpretation as it is always an estimate of the concentration which causes a response of xx %.

The major criticism regarding the ECxx concept is the need of specifying a mathematical model for the concentration-response relation. Such a model is not needed for the NOEC. However, a library of standard concentration-response models exists, from which an appropriate problem-specific model can be selected. For the example of the FET, a binary four-parameter logistic model (see Fig. 1a and Appendix) has been found suitable [2729]. The ECxx concept does not rely on using the logistic model; it can be adapted to every other strictly monotone concentration-response model. Also, non-parametric approaches can be used [26].

Different from the NOEC approach, a CI can be calculated for ECxx as a measure of precision. The width of the ECxx confidence interval depends, among others, on the value of xx. In contrast to the NOEC, ECxx itself does not depend on the design of the experiment, which makes interlaboratory comparisons of ECxx more consistent than comparing NOEC values [14], even if different experimental designs are involved.

When setting up a design for an experiment to determine acceptable concentrations in health prevention and environmental conservation, the main insight is that concentrations of small effects such as EC01, EC05, EC10 are relevant. Designs optimized for detecting EC50 are not suitable, but it is straightforward to build a design optimized for any specified effect size xx. There is no way to do so if a NOEC is used as risk quantification, because the NOEC concept means to search for an effect of zero, not for an effect of size xx > 0. Considering the advantages and disadvantages of both risk quantification concepts, we concluded using the ECxx concept. NOECs are still used and generated by other authors [18, 30] despite their adverse properties and the debate to abandon them, which has been ongoing for more than 30 years. NOECs are not generated in this package because of the described reasons above.

The procedure for designing an experiment according to the strategy outlined in the ‘Methods’ section is implemented in the open-source statistic software R as the software package toxtestD, which is described below. Power consideration is part of the package, as requested since quite some time [31].

The need of a good experimental design is a well-communicated issue, but only a few publications on the FET made reference to this [32], as well as current publications to concentration-response relationships [33]. The chosen procedure affects the sample size and the selection of concentrations in the experiment. Sample size will be a balance between contrasting interests: a high precision of the estimated EC, which requires a high number of biological organisms in the test, and the ethical and the economic aspects, which require using few objects. Even though embryos are not considered to be living organisms and are therefore not protected by animal welfare regulations [34], they are animals by ethical considerations [35]. Both interests ask for avoiding experiments which are uninformative because of too few test organisms. Following the suggested design, the experiments should be organized such that the effect of interest can be detected with reasonable precision without involving more biological organisms than necessary. We explicitly recommend following the suggested steps. Especially, the first step should be designed as single experiment for determining the spontaneous lethality (SL). The SL is an indication for the health of the breed and describes the response rate under control conditions. It should be determined with precision because it serves as a baseline for subsequent calculations. As the health status of breed may depend on lab conditions, the design of the experiment may be lab-specific. This give a serious baseline for the further experiments, the detection of the group size per concentration, and the allocation of concentrations for the main experiment. The consideration of SL is precisely important in FET. With the general approach described in this paper, the user is free to choose the necessary adjustments depending on the purpose and object.

The methods implemented in the package apply not only for the analysis of FET data but also to all other dose-response analysis tasks involving a binary target quantity. In all these cases, test designs can be developed which include a properly defined ECxx by specifying the risk type and a reasonable power by regarding the error types I and II (see ‘Methods” section for more explanations).

Conclusions

The quality of biological test procedures like the FET relies on using it in an appropriate experimental design. Test results are used for risk assessment and risk management. It is highly desirable that underlying tests are run transparently, with a sufficient number of objects warranting small error rates. Ethical considerations require concomitantly that samples larger than required to attain the accepted error rates should be avoided. This paper discusses standard approaches of risk quantification, concluding that the effect-oriented ECxx concept for effect quantification is more favourable than the test-oriented NOEC concept. We therefore propose the effect size-oriented approach adjusted to small target effects. We suggest a way to organize an experiment according to this conclusion. Realizing such an experimental design is facilitated by the R software package toxtestD, which has been introduced in this paper. It organizes the design process in three steps. Being an open-source product, it is available for everybody and allows designing proper experiments also for non-statisticians. The procedure will be specific for the target quantity to be determined with the user-required precision and safety for the quantities of interest.

Methods

Basic considerations for an optimal test design

Error types

For calculation of the optimal test conditions, it is necessary to consider different error types as mathematical principals such as significance, power, and precision. In general, considering two concentrations (i.e. negative control and a test concentration >0), the associated observed effects are random values from two different distributions with concentration-specific mean values (Fig. 2). If the test concentration has no effect, both distributions and their means are identical. If the test concentration has an effect, the associated mean is higher than the control group mean. The two distributions will in general show a certain overlap. If the test concentration in an experiment generates a result in the overlapping range, it cannot safely be concluded from this result that the test concentration has a systematic effect greater than the control group. The observed value has a considerable probability also under control conditions (Fig. 2a). This means that two different errors may occur when assessing response data from control and test concentrations. A type I error occurs if an effect is interpreted as a concentration effect although it is an effect of the negative control (Fig. 2b). The probability α of a type I error, also known as the level of significance (the p value), reflects the risk of the producer [36]. To keep the danger of a type I error small, the empirical significance level is computed in an actual statistical test procedure, and only if this probability is small (smaller than or equal to a pre-specified α), it is concluded that the test concentration had a systematically higher effect than the control condition. The default value for α is 0.05 or 5 %. The other error that might occur in a statistical test is that a systematically higher response from the test concentration is not recognized as such, so that an existing effect remains undetected (Fig. 2c). This is the type II error, the probability of which should also be restricted to a reasonable value. It reflects the risk of the consumer. A typical value for the accepted type II error is β = 0.20 or 20 %. The complementary probability of the type II error (= 1 − β), which is the probability of detecting a systematic difference between responses, is also known as the power or quality of the test. Consideration of the type II error seems to be much less common than considering the type I error [37], possibly because it demands an extra effort, but it is a constitutional component of experimental design. The probabilities of both errors depend (among others) on the group sizes involved. Increasing group sizes is the only way to reduce both error probabilities, and consequently, the crucial step in sample size planning is finding the minimal group sizes for which the accepted sizes of both errors are not exceeded (Fig. 1b). The distributions shown in Figs. 2 and 1b get narrower with increasing group size, which decreases the zone in which values from both groups overlap so that observations can more safely be attributed to one of the groups.
Fig. 2

Error type I and type II: Two distributions with an overlapping area (a), red marked area of type I error (b), green marked area of type II error (c). The dotted lines mark the mean values of each distribution

The present proposal uses α = 5 % and β = 20 % as defaults for accepted errors. Both values are not fixed but are frequently used in experimental design. They may be changed, but the user should be careful when relaxing these defaults, as too liberal requirements make the test procedure ineffectual. It should be kept in mind that with a β close to 50 %, the user will declare a truly existing effect with a probability of 50 % as not existing. This situation is equivalent to tossing a coin to obtain the test result. Obviously, a power analysis compliant to the individual target is a fundamental component in experimental design [17].

Risk types

There are various ways of defining the response percentage (the xx part in ECxx), differing by the way how the spontaneous and the immune level are incorporated. Three different common types of risks are considered here. They differ in the way of how the concentration-related increase in the response is expressed. They will further be named as risk types. Each risk type (Fig. 3) has its own interpretation of xx and its specific value for ECxx, and it may also require its own specific experimental design. The risk types used here are extended versions of the US Environmental Protection Agency (EPA) definitions [38], whereas the extension consists in the additional consideration of immunity (IY) [28, 29]. Immunity describes the phenomenon that within a population, a subpopulation shows by chance no reaction at all. The EPA definitions result by setting IY = 0 %.
Fig. 3

Risk types and their conversions: 1 total risk (TR), 2 added risk (AR), 3 extra risk (ER). IY immunity, SL spontaneous lethality, xx target value (shown example = 10 %); converted values, max AR = [100 − SL]; TR xx = xx = 10 %; AR xx = [SL + xx] = SL + 10 %; ER xx = xx/100 · [100 − SL − IY] = 0.1 · [100 − SL − IY]

  1. 1.

    Total risk (TR): The total risk is the total response expressed as percentage of affected biological units among all treated units. Spontaneous lethality and immunity are ignored. Example: A desired xx = 10 % will force estimation of the concentration that generates an effect of 10 % (Fig. 3 (1)).

     
  2. 2.

    Added risk (AR): The reference frame is restricted below and above by spontaneous lethality and immunity. Only the response above the SL counts as an effect. Using AR, the total response associated with a target effect of size xx and a spontaneous lethality SL is xx + SL. Example: A desired AR of xx = 10 % and SL = 3.5 %, IY = 7 %, prompts estimating the concentration producing an effect of 10 % above the SL, equivalent to a total response of 13.5 %. The immunity parameter does generally not affect the ECxx value but restricts its possible maximum to [100 % − SL − IY] (Fig. 3 (2)).

     
  3. 3.

    Extra risk (ER): The reference frame is the interval from SL to [100 % − IY]. Example: A desired ER with xx = 10 % and SL = 3.5 %, IY = 7 %, will force estimating the concentration which generates a total response of [SL + 0.01 · xx · (100 % − SL − IY)] = 3.5 % + 0.01 · 10 · (100 % − 3.5 % − 7 %) = 12.45 % (Fig. 3 (3)).

     

The total response associated with a target effect of xx and using ER as risk type is smaller than or equal to the total response associated with the same xx, but with risk type AR.

Proposed software solution (toxtestD) for an optimal test design

To consider all our proposals, we implemented a package with a set of functions in R code [39], which do experimental design as outlined above in a user-friendly way. The R software is an open-source software. The package requires only a few inputs by the user. Sophisticated statistical understanding or modelling experiences are not necessary (though useful). Even though the concept is drafted for the fish embryo toxicity assay, it is possible to transfer the procedure in principle to all other toxicological questions, in which a continuous concentration equivalent generates a yes/no (binary) response per single study object. The package toxtestD should already be consulted during the planning phase of a test series. It contains the functions spoD, setD, and doseD which cover identification of the spontaneous lethality, the estimation of the necessary number of test organisms, and a concentration design according to the user’s requirements. Examples for the application of all these functions are available after installation of the package by the command help (toxtestD) [40].

Determination of the spontaneous lethality by spoD

The first task when designing the experiment is calculating the sample size for determining the SL. The necessary sample size depends on the required precision of the estimated SL. It should be recalled that because SL will be calculated from data containing random variation, the resulting SL will also be a quantity with random error.

The function spoD offers two services. In the planning process, the total number of individuals or eggs to test is calculated, together with a proposal for partitioning the total data set into subgroups in order to identify the amount of biological variation in the separated tests. The calculations will be done for the denoted rate and additionally for the worst case in the interval given for the predicted SL. The optimal number of biological units is calculated by using an exact binomial test with α and β as specified. The previous mentioned random error can be quantified by a CI (see Appendix for calculation details), which contains the true value of SL (the response that would hold if no random fluctuation were present) with large probability, typically 95 %. We propose that as a default requirement, the limits of the CI for the SL should differ from the estimated SL by no more than ± 2.5 % (further on denoted by maxCI).

In the analysis process (initiated by setting analysis = TRUE), the spontaneous lethality together with its 95 % confidence interval and the biological variation are computed from the user’s data. Biological variation becomes visible when comparing spontaneous rates from several experiments under control conditions. A χ 2 test is applied to check whether these rates vary according to binomial variation under the hypothesis of the same true spontaneous rate for all experiments. A significant result signals the presence of biological variation between experiments. If present, its standard deviation is reported. It is recommended to determine the spontaneous lethality very early under separate test conditions.

Specifications by the user

Subprocess planning

n: The maximal number (integer) of test organisms, with which the laboratory is willing to cope. Limiting the number is necessary to avoid non-essential calculations and thereby save computing time. The programme will invite the user to increase the number if the number is not high enough to estimate the SL with the given precision requirement.

SL.p: (optional SLmin, SLmax): To gain an optimal number of test objects for the determination of the true spontaneous lethality, the user needs at least a rough idea about the SL prior to test planning. This estimate is inserted in SL. It is possible to specify the SL either as single number or as an interval between 0 and 100 %. The maximum tolerated spontaneous lethality by OECD is 10 %. Datasets with higher SL should be discarded [9].

bio.sd.p (optional): The standard deviation of SL consists of normal random variation and a biological variation due to biological effects like season, daytime, or wellbeing. The default value of 2.008 % for bio.sd.p was determined from empirical data sets collected over 10 years by the Thünen Institute, Hamburg, Germany (U. Kammann and S. Schubert, personal communication) [41]. The value refers exclusively to dead eggs and lethal malformations (pursuant to the definition in DIN ENISO 15088) after 96 hpf in water in per cent [4, 9]. If not specified otherwise, this default will be used for determining the optimal number of partitions.

maxCI (optional): It is the maximally accepted absolute difference in per cent between mean SL and its confidence limits; default, 2.5 %.

print.result: If omitted, the result is written to a text file called ‘01_spontaneous lethality.txt’ in the calling directory. If a file name is given in double quotes, the result is written to that file. Nothing is written if FALSE is chosen.

Subprocess analysis

analysis: The default value is FALSE, indicating that the function does planning. To analyse the own dataset, choose analysis = TRUE.

SLdataset: This is the R data frame containing the experimental data. It needs two columns titled ‘n’ and ‘bearer’. In column n, the total number of observations of each single experimental run is listed. The column bearer comprises the number of organisms which are carriers (in the case of FET the counts of dead or lethal malformed eggs) within each single experimental run. Each row contains the outcome from one single experimental run.

Determination of the optimal number for each experimental run by setD

The second task should be the calculation of the optimal number per experimental run. The proposed calculations in setD involve a robustness consideration as it is done in the third task. We propose for every concentration in the FET a sample size such that a test for a concentration effect of size xx at the sought concentration ECxx would detect this effect with a high (pre-specified) probability. Requiring a specified quality of the test leads to the necessary sample size per concentration. Two distributions will be estimated, one assuming SL as true response level, the other using SL + xx defined above (Fig. 1). The estimation of these two distributions bases on binomial probability. The default of the distance is xx % in respect to a posterior target of ECxx. Additionally the distance depends on the reference frame. In consequence, it is necessary to choose the convenient risk type (see section ‘Risk types’). The procedure increases the number of cases per concentration until the overlapping area of the two distributions corresponds to the specified levels of error types I and II (Fig. 1b).

Specifications by the user

nmax: Number (integer) of the maximum available number of organisms that can be tested in each treatment within an experimental run. The estimation of the optimal number will only start when this number is high enough to generate the response of at least one organism (nmax · p > 1). If the chosen nmax is too small, a warning message is issued

SL.p: SL is calculated in per cent from own experimental data by the process spoD

immunity.p: A population of biological objects might contain a subpopulation which shows no reaction at all. Consequently, a reaction of 100 % will never be reached [42]. We call this effect immunity in our procedure. To account for this kind of non-response, the size of the immune subpopulation can be specified as percentage of the total population. The concentration-response curve then has [100 % − IY] as maximum. Please choose risk.type = 3 to include immunity in all calculations

risk.type: Please choose one of three risk types. Each type defines a specific reference frame for the concentration-response curve (for detailed information see the ‘Risk types’ section)

target.EC.p: The target response in per cent (e.g. 10 %, to calculate EC10). Note that the interpretation of target.EC depends on the risk.type setting

plot: There are three possibilities:

plot = FALSE: no plots

plot = ‘single’: creates only one plot showing the two distributions under SL and under treated conditions with the optimal number of cases. Additionally, the real rates of error type one and two are given (see Fig. 1b). The special setting for risk.type is not included into this plot

plot = ‘all’: In addition to the single plot, this option provides an estimation for all possibilities of target values. This gives an impression which possibilities of detection exist under the chosen conditions. This option may need a lot of computer capacity and time. It should not be activated in general.

alpha.p & beta.p: See explanations in ‘Error types’ section

print.result: If omitted, the result is written to a text file called ‘02_sample size.txt’ in the calling directory. If a file name is given in double quotes, the result is written to that file. Nothing is written if FALSE is chosen

Allocating concentration points by doseD

The third task, defining the concentration allocation for the main experiment, is guided by an idea of robustness similar to the second task. From a formal point of view, only as many concentration points as unknown parameters in the dose-response model are needed. It would however be unwise to involve only this minimum because it would not allow model checks. Concentration allocation needs at least a vague idea about position and scale of the concentration-response curve. Concentration-finding experiments, pilot studies, literature data, and similar sources are used to obtain these planning assumptions. Given an initial assumption, we propose the following concentration allocation strategy: calculate EC10, EC50, EC90 from the planning assumptions, assuming a logistic concentration-response relation and involving SL and IY, if the selected risk type requires so. The control concentration of zero and these three concentrations plus target concentrations, given by the ECxx values of the experimenter’s interest, constitute the concentration allocation pattern for the main experiment. Two-sided CIs with 95 and 99 % coverage probability will be calculated for the concentration-response curve. If more than four concentration points are chosen and there is an even number of free points, these will be allocated symmetrically around the chosen ECxx value. If two free points are available, these are located at the limits of the 95 % CI. If an even number of 4 or more free points is available, these are allocated equidistantly in the 99 % CI. For an odd number of free points, 1 point is located at ECxx and the others are allocated according to the rule for an even number. Note that the 1 of EC10, EC50, EC90 can be used twice as an experimental concentration, if the user’s target coincides with one of these. The strategy prefers low concentrations if several targets are specified by the user. This pattern is a robust strategy which focuses on the main interest of finding ECxx but does not rely too strongly on the planning assumptions. If previous experience suggests that the planning assumptions are realistic, concentrations could be allocated more closely around the presumed ECxx.

Specifications by the user

DP: The results from pre-tests must be given as a data frame with the columns ‘name’, ‘organisms’, ‘death’, ‘concentration’ and ‘unit’, which will be needed for the calculations of the dose scheme

immunity.p: immunity in per cent (see also settings of spoD)

SL.p: SL is calculated in percent from the user’s experimental data by the function spoD

target.EC.p: effect in %, which is of special interest. It is possible to denote more than one target in the same calculation. For example: if EC5 and EC10 are of special interest, then target. EC = c (5,10) may be chosen, and the dose points will be allocated around both targets

nconc: number of different concentrations the user is willing to test in each cycle

text: text = TRUE adds extended information in the plot

risk.type: Please choose one of three possible risk types. Each type defines another reference frame for concentration-response curve and target estimation (for detailed information see the ‘Risk types’ section). A plot for each risk type will be created separately

print.result: If omitted, the result is written to a text file called ‘03.dosestrategy.txt’ in the calling directory. If a file name is given in double quotes, the result is written to that file. Nothing is written if FALSE is chosen.

Abbreviations

AR: 

Added risk

ASTM: 

ASTM International, known until 2001 as the American Society for Testing and Materials

BMD: 

Benchmark dose

DIN: 

German Institute for Standardization

EC: 

Effective concentration

ED: 

Effective dose

EPA: 

US Environmental Protection Agency

ER: 

Extra risk

FET: 

Fish embryo toxicity test

hpf: 

Hours post fertilization

IY: 

Immunity

LC: 

Lethal concentration

LD: 

Lethal dose

NOEC: 

No observed effect concentration

OECD: 

Organisation for Economic Co-operation and Development

REACH: 

Registration, Evaluation, Authorisation and Restriction of Chemicals

SL: 

Spontaneous lethality

TR: 

Total risk

VSD: 

Virtual safe dose

Declarations

Acknowledgments

The authors thank Malte Damerau, Ulrike Kammann, Michael Haarich and Norbert Theobald for their thematic support. This study was incorporated into ‘MERIT-MSFD: Methods for detection and assessment of risks for the marine ecosystem due to toxic contaminants in relation to implementation of the European Marine Strategy Framework Directive’. It was supported by a grant (grant number 10017012) from the German Federal Ministry of Transport and Digital Infrastructure (BMVI) and the German Maritime and Hydrographic Agency (BSH).

Authors’ Affiliations

(1)
Institute of Fisheries Ecology, Thünen Institute (TI)
(2)
Institute of Statistics, University of Bremen

References

  1. r-project. http://cran.r-project.org/. 2015: Accessed: 18 Dec 2014.
  2. Keddig N, Wosniok W. toxtestD package manual. http://cran.r-project.org/web/packages/toxtestD/toxtestD.pdf. 2014.
  3. Lammer E, Carr GJ, Wendler K, Rawlings JM, Belanger SE, Braunbeck T. Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2009;149(2):196–209. http://dx.doi.org/10.1016/j.cbpc.2008.11.006.
  4. German Institute for Standardisation (DIN). Wasserbeschaffenheit – Bestimmung der akuten Toxizität von Abwasser auf Zebrafisch-Eier (Danio rerio) (ISO 15088:2007). DIN EN ISO 15088. 2009.Google Scholar
  5. Keiter S, Peddinghaus S, Feiler U, von der Goltz B, Hafner C, Ho NY, et al. A novel joint research project using zebrafish (Danio rerio) to identify specific toxicity and molecular modes of action of sediment-bound pollutants. J Soils Sediments. 2010;10:714–7. doi:https://doi.org/10.1007/s11368-010-0221-7.View ArticleGoogle Scholar
  6. Research Centre for Toxic Compounds in the Environment. http://www.recetox.muni.cz/index-en.php?pg=research-and-development--analyses-and-services--ecotoxicology. 2014: Accessed: 01 Apr 2014.
  7. Fraunhofer-Gesellschaft. http://www.ime.fraunhofer.de/de/geschaeftsfelderAE/Verbleib_und_Wirkung_Agrochemikalien/Erweiterte_Standardtests.html#tabpanel-5. 2014: Accessed: 01 Apr 2014.
  8. Microtest Laboratories. http://www.microtestlabs.com. 2014: Accessed: 1 Apr 2014.
  9. Organisation for Economic Co-operation and Development. OECD guidelines for the testing of chemicals - fish embryo acute toxicity (FET) test. 2013;236 (adopted 26 July 2013).Google Scholar
  10. Hutchinson TH, Solbe J, Kloepper-Sams PJ. Analysis of the ecetoc aquatic toxicity (EAT) database III—comparative toxicity of chemical substances to different life stages of aquatic organisms. Chemosphere. 1998;36(1):129–42. http://dx.doi.org/10.1016/S0045-6535(97)10025-X.View ArticleGoogle Scholar
  11. Crump KS. Calculation of benchmark doses from continuous data. Risk Anal. 1995;15(1):79–89.View ArticleGoogle Scholar
  12. European Chemicals Agency. Guidance on information requirements and chemical safety assessment Chapter R.10: Characterisation of dose [concentration]-response for environment. 2008. http://echa.europa.eu/documents/10162/13632/information_requirements_r10_en.pdf.
  13. Van Der Hoeven N. How to measure no effect. Part III: statistical aspects of NOEC, ECx and NEC estimates. Environmetrics. 1997;8(3):255–61. doi:https://doi.org/10.1002/(SICI)1099-095X(199705)8%3A3%3C255%3A%3AAID-ENV246%3E3.0.CO%3B2-P.View ArticleGoogle Scholar
  14. Chapman PM, Caldwell RS, Chapman PF. A warning: NOECs are inappropriate for regulatory use. Environ Toxicol Chem. 1996;15:77–9.View ArticleGoogle Scholar
  15. Crane M, Newman MC. What level of effect is a no observed effect? Environ Toxicol Chem. 2000;19(2):516–9. doi:https://doi.org/10.1002/etc.5620190234.View ArticleGoogle Scholar
  16. Moore DRJ, Caux P-Y. Estimating low toxic effects. Environ Toxicol Chem. 1997;16(4):794–801. doi:https://doi.org/10.1002/etc.5620160425.View ArticleGoogle Scholar
  17. Warne MSJ, van Dam R. NOEC and LOEC data should no longer be generated or used. Australas J Ecotoxicol. 2008;14:1–5.Google Scholar
  18. Landis WG, Chapman PM. Well past time to stop using NOELs and LOELs. Integr Environ Assess Manag. 2011;7(4):vi–vii. doi:https://doi.org/10.1002/ieam.249.View ArticleGoogle Scholar
  19. Grasso P. Essentials of pathology for toxicologists. Taylor & Francis Inc., London, New York 2002.Google Scholar
  20. van Ewijk PH, Hoekstra JA. Calculation of the EC50 and its confidence interval when subtoxic stimulus is present. Ecotoxicol Environ Saf. 1993;25(1):25–32. http://dx.doi.org/10.1006/eesa.1993.1003.View ArticleGoogle Scholar
  21. European Union. Directive 2008/56/EG - Marine strategy framework directive. In: Union OJotE, editor.2008.Google Scholar
  22. Federal Institute for Occupational Safety and Health, (BAuA). Hazardous substances ordinance (Gefahrstoffverordnung – GefStoffV). 2010; updated. 2013.Google Scholar
  23. Institute for Health and Consumer Protection. Technical guidance document on risk assessment. 2003.Google Scholar
  24. European Union. Regulation (EC) No 1907/2006 of the European Parliament and of the council. 2006.Google Scholar
  25. Fraysse B, Mons R, Garric J. Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. Ecotoxicology and Environmental Safety. 2006;63(2):253–67. http://dx.doi.org/10.1016/j.ecoenv.2004.10.015.
  26. Piegorsch WW, Xiong H, Bhattacharya RN, Lin L. Benchmark dose analysis via nonparametric regression modeling. Risk analysis: an official publication of the Society for Risk Analysis. 2013:1–17. https://doi.org/10.1111/risa.12066.
  27. Kammann U, Vobach M, Wosniok W, Schäffer A, Telscher A. Acute toxicity of 353-nonylphenol and its metabolites for zebrafish embryos. Environ Sci Pollut Res. 2009;16(2):227–31.View ArticleGoogle Scholar
  28. Ratkowsky DA, Reedy TJ. Choosing near-linear parameters in the four-parameter logistic model for radioligand and related assays. Biometrics. 1986;42(3):575–82. doi:https://doi.org/10.2307/2531207.View ArticleGoogle Scholar
  29. DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol Gastrointest Liver Physiol. 1978;235(2):G97–G102.Google Scholar
  30. Carlsson G, Patring J, Kreuger J, Norrgren L, Oskarsson A. Toxicity of 15 veterinary pharmaceuticals in zebrafish (Danio rerio) embryo. Aquat Toxicol. 2013;126(0):30–41. http://dx.doi.org/10.1016/j.aquatox.2012.10.008.View ArticleGoogle Scholar
  31. Hayes JP. The positive approach to negative results in toxicology studies. Ecotoxicol Environ Saf. 1987;14(1):73–7. http://dx.doi.org/10.1016/0147-6513(87)90085-6.View ArticleGoogle Scholar
  32. Wedekind C, von Siebenthal B, Gingold R. The weaker points of fish acute toxicity tests and how tests on embryos can solve some issues. Environ Pollut. 2007;148(2):385–9. http://dx.doi.org/10.1016/j.envpol.2006.11.022.View ArticleGoogle Scholar
  33. Kent M, Buchner C, Barton C, Tanguay R. Toxicity of chlorine to zebrafish embryos. Dis Aquat Org. 2014;107(3):235–40. doi:https://doi.org/10.3354/dao02683.View ArticleGoogle Scholar
  34. European Union. Directive 2010/63/EU of the European Parliament and of the council on the protection of animals used for scientific purposes. In: Union OJotE, editor.2010. p. 33–79.Google Scholar
  35. Braunbeck T, Böttcher M, Hollert H, Kosmehl T, Lammer E, Leist E, et al. Towards an alternative for the acute fish LC (50) test in chemical assessment: the fish embryo toxicity test goes multi-species—an update. Altex. 2004;22(2):87–102.Google Scholar
  36. Gad SC. Statistics and experimental design for toxicologists and pharmacologists. Taylor & Francis Group, LLC, Boca Raton, London, New York, Singapore; 2005.Google Scholar
  37. Fairweather PG. Statistical power and design requirements for environmental monitoring. Mar Freshw Res. 1991;42(5):555–67.View ArticleGoogle Scholar
  38. United States Environmental Protection Agency (U.S. EPA). EPA’s approach for assessing the risks associated with chronic exposure to carcinogens—Integrated Risk Information System (IRIS): http://www.epa.gov/iris/carcino.htm. 1992: Accessed 10 Sept 2014.
  39. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2014;Vienna, Austria. http://www.R-project.org/
  40. Keddig N, Wosniok W. toxtestD package—experimental design for binary toxicity tests (with examples). 2014. http://cran.r-project.org/web/packages/toxtestD/index.html.
  41. Kammann U, Vobach M, Wosniok W. Toxic effects of brominated indoles and phenols on zebrafish embryos. Arch Environ Contam Toxicol. 2006;51(1):97–102. doi:https://doi.org/10.1007/s00244-005-0152-2.View ArticleGoogle Scholar
  42. Dinse G, An EM. Algorithm for fitting a four-parameter logistic model to binary dose-response data. JABES. 2011;16(2):221–32. doi:https://doi.org/10.1007/s13253-010-0045-3.View ArticleGoogle Scholar
  43. Johnson NL, Kotz S. Distributions in statistics: discrete distributions. Wiley Interscience; New York; Brisbane 1969.Google Scholar

Copyright

© Keddig et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.